The FDA announced that it had received reports of cancers, including a type of lymphoma, in people who received treatment with certain chimeric antigen receptor T-cell or CAR-T therapies.
#Cancer #CancerDrugs #InformedConsent
https://www.yahoo.com/lifestyle/fda-investigating-risk-secondary-cancers-192522497.html?
#Cancer #CancerDrugs #InformedConsent
https://www.yahoo.com/lifestyle/fda-investigating-risk-secondary-cancers-192522497.html?
Yahoo Life
FDA investigating risk of secondary cancers after CAR-T therapy to treat cancer
The US Food and Drug Administration has launched an investigation into certain treatments for cancer and whether these therapies themselves may be associated with the risk of developing secondary cancers.
"For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary."
#Cancer #CancerDrugs #Pharmaceuticals #Healthcare
https://www.myjournalcourier.com/news/article/patients-doctors-push-back-cancer-drugs-side-18652030.php
#Cancer #CancerDrugs #Pharmaceuticals #Healthcare
https://www.myjournalcourier.com/news/article/patients-doctors-push-back-cancer-drugs-side-18652030.php
Jacksonville Journal-Courier
As cancer treatment advances, patients push back against drugs
The U.S. Food and Drug Administration is pushing drugmakers to do a better job at...
"Global spending for oncology drugs is projected to rise from $167 billion in 2020 to $269 billion in 2025.
What's more, an increasing number of oncology drugs are approved on less robust evidence, raising concerns about misalignment of incentives in the pharmaceutical market with patient interests."
#Pharmaceuticals #BigPharma #Cancer #CancerDrugs #CancerRacket
https://medicalxpress.com/news/2024-02-significant-proportion-cancer-drugs-lack.html
What's more, an increasing number of oncology drugs are approved on less robust evidence, raising concerns about misalignment of incentives in the pharmaceutical market with patient interests."
#Pharmaceuticals #BigPharma #Cancer #CancerDrugs #CancerRacket
https://medicalxpress.com/news/2024-02-significant-proportion-cancer-drugs-lack.html
Medicalxpress
Significant proportion of cancer drugs lack proof of added benefit, finds study
Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited ("fast track") pathways, finds a study ...
#Chemo Speeds Up Physical Decline in Older Women
#Cancer #CancerDrugs #InformedConsent
https://www.yahoo.com/news/chemotherapy-speeds-physical-decline-older-163440613.html
#Cancer #CancerDrugs #InformedConsent
https://www.yahoo.com/news/chemotherapy-speeds-physical-decline-older-163440613.html
Yahoo News
Chemotherapy Speeds Up Physical Decline in Older Women—But Certain Interventions Can Help
A new study on breast cancer in older women shows that chemotherapy can negatively impact physical functioning. Here's how experts say that can be avoided.
Cancer patients often do better with less intensive treatment, new research finds
#Cancer #CancerDrugs #Chemo #CancerPatients #Healthcare #Pharmaceuticals #InformedChoice #InformedConsent
https://www.yahoo.com/news/cancer-patients-often-better-less-120121727.html
#Cancer #CancerDrugs #Chemo #CancerPatients #Healthcare #Pharmaceuticals #InformedChoice #InformedConsent
https://www.yahoo.com/news/cancer-patients-often-better-less-120121727.html
Yahoo News
Cancer patients often do better with less intensive treatment, new research finds
Scaling back treatment for three kinds of cancer can make life easier for patients without compromising outcomes, doctors reported at the world’s largest cancer conference. It’s part of a long-term trend toward studying whether doing less — less surgery,…